BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pipili C, Cholongitas E. Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipients. World J Gastrointest Pharmacol Ther 2015; 6(4): 105-110 [PMID: 26558143 DOI: 10.4292/wjgpt.v6.i4.105]
URL: https://www.wjgnet.com/2220-3230/full/v6/i4/105.htm
Number Citing Articles
1
Evangelos Cholongitas, George V. Papatheodoridis. Hepatitis C: Care and Treatment2021; : 175 doi: 10.1007/978-3-030-67762-6_12
2
Evangelos Cholongitas, Chrysoula Pipili, George V Papatheodoridis. Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantationWorld Journal of Hepatology 2017; 9(4): 180-190 doi: 10.4254/wjh.v9.i4.180
3
Marco Ladino, Fernando Pedraza, David Roth. Hepatitis C Virus Infection in Chronic Kidney DiseaseJournal of the American Society of Nephrology 2016; 27(8): 2238 doi: 10.1681/ASN.2016010030
4
Ryoichi Miyazaki, Kyoko Miyagi. Successful treatment of chronic hepatitis C virus genotype 1b infection of a patient with compensated cirrhosis after renal transplantation using daclatasvir-asunaprevir combination therapy: a case report and literature reviewRenal Replacement Therapy 2016; 2(1) doi: 10.1186/s41100-016-0075-6